Clinical trial

A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of…

NCT00394966 · Schering-Plough, Industry · Completed

Key facts

NCT number NCT00394966
Title A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)
Official title A Phase 2, MultiCenter, Randomized, Placebo-Controlled, Double-Blind, Dose Finding Study to Determine the Safety and Efficacy of SCH 619734 for the Treatment of Chemotherapy Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
Lead sponsor Schering-Plough, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Nausea, Vomiting
Intervention type Drug
Interventions SCH 619734 Dose 1, SCH 619734 Dose 2, SCH 619734 Dose 3, SCH 619734 Dose 4, Placebo
Enrollment 450
Start date Sep 1, 2006
Primary completion Mar 1, 2008
Completion Mar 1, 2008
First posted Nov 2, 2006
Last update posted Oct 23, 2009

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies